+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 644981-35-1
644981-35-1,MFCD30377205
Catalog No.:AA00ECDQ

644981-35-1 | Val-Cit-PAB-MMAE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
95%
in stock  
$216.00   $152.00
- +
10mg
95%
in stock  
$304.00   $213.00
- +
100mg
99%
in stock  
$481.00   $337.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00ECDQ
Chemical Name:
Val-Cit-PAB-MMAE
CAS Number:
644981-35-1
Molecular Formula:
C58H94N10O12
Molecular Weight:
1123.4268
MDL Number:
MFCD30377205
SMILES:
CC[C@@H]([C@H](N(C(=O)[C@H](C(C)C)NC(=O)[C@@H](N(C(=O)OCc1ccc(cc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)N)CCCNC(=O)N)C)C(C)C)C)[C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@H](C(=O)N[C@@H]([C@H](c1ccccc1)O)C)C)OC)OC)C
Properties
Computed Properties
 
Complexity:
1980  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
12  
Heavy Atom Count:
80  
Hydrogen Bond Acceptor Count:
13  
Hydrogen Bond Donor Count:
8  
Rotatable Bond Count:
32  
XLogP3:
4.4  

Downstream Synthesis Route

[1]Tang,Feng;Yang,Yang;Tang,Yubo;Tang,Shuai;Yang,Liyun;Sun,Bingyang;Jiang,Bofeng;Dong,Jinhua;Liu,Hong;Huang,Min;Geng,Mei-Yu;Huang,Wei[OrganicandBiomolecularChemistry,2016,vol.14,#40,p.9501-9518]

[2]CurrentPatentAssignee:REMEGEN-US2022/72137,2022,A1Locationinpatent:Paragraph0169;0171

[3]CurrentPatentAssignee:SHENZHENENDURINGBIOTECH;SHENZHENKANGYUANLONGTERMBIOTECHNOLOGYLTD-WO2021/209007,2021,A1Locationinpatent:Page/Pagecolumn55-56;58;60

[4]CurrentPatentAssignee:NANJINGCHEMPIONBIOTECHNOLOGY-WO2022/161452,2022,A1Locationinpatent:Page/Pagecolumn66-67

[5]CurrentPatentAssignee:REGENERONPHARMACEUTICALSINC-US2018/333504,2018,A1Locationinpatent:Paragraph0373

[6]CurrentPatentAssignee:ONTARIOINSTITUTEFORCANCERRESEARCH-WO2019/109188,2019,A1Locationinpatent:Paragraph00308;00310

[7]CurrentPatentAssignee:ONTARIOINSTITUTEFORCANCERRESEARCH-WO2019/119141,2019,A1Locationinpatent:Paragraph00221;00277;00279

[8]CurrentPatentAssignee:ANTIKORBIOPHARMA-WO2016/46574,2016,A1Locationinpatent:Page/Pagecolumn144

[9]Manabe,Shino;Yamaguchi,Yoshiki;Matsumoto,Kana;Fuchigami,Hirobumi;Kawase,Taiji;Hirose,Kenji;Mitani,Ai;Sumiyoshi,Wataru;Kinoshita,Takashi;Abe,Junpei;Yasunaga,Masahiro;Matsumura,Yasuhiro;Ito,Yukishige[BioconjugateChemistry,2019,vol.30,#5,p.1343-1355]

[10]CurrentPatentAssignee:UNIVERSITYOFCAMBRIDGE-WO2020/25108,2020,A1Locationinpatent:Page/Pagecolumn48-49

[11]CurrentPatentAssignee:REMEGEN-US2020/138968,2020,A1Locationinpatent:Paragraph0070-0071;0074-0075

[12]CurrentPatentAssignee:SPIREA-WO2020/128488,2020,A1Locationinpatent:Page/Pagecolumn84-85

[13]CurrentPatentAssignee:SEAGENINC-US2021/300867,2021,A1Locationinpatent:Paragraph0551;0554

[14]CurrentPatentAssignee:DEBIOPHARMRESMANUFACTURING-WO2022/79031,2022,A1Locationinpatent:Page/Pagecolumn201-202

Literature

Title: Okeley, et al. Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate. Clinical Cancer Research (2010), 16(3), 888-897.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 644981-35-1
1411977-95-1

1411977-95-1

 1350456-56-2

1350456-56-2

 863971-17-9

863971-17-9

 2259318-46-0

2259318-46-0

 1491152-26-1

1491152-26-1
Building Blocks
More >
Tags:644981-35-1 Molecular Formula|644981-35-1 MDL|644981-35-1 SMILES|644981-35-1 Val-Cit-PAB-MMAE